
It's hard to watch someone choose to end or forgo conventional treatment without succumbing to the urge to educate. But education isn't always what patients need.

It's hard to watch someone choose to end or forgo conventional treatment without succumbing to the urge to educate. But education isn't always what patients need.

Some of us fumble more than others. I was one of those emotional wrecks, wearing my emotions on my sleeve.

With summer over, two-time cancer survivor and clutter-clearing author shares time management help with a cancer-enhanced awareness that her time is her life.

The risk of relapse dropped 53 percent when trametinib and dabrafenib were used after therapy.

Research announced at the Madrid conference could radically change treatment for lung cancer, melanoma and kidney cancer

Patients, survivors and their caregivers may not be getting the whole picture as presented by the lay media.

Extended use of aromatase inhibitors (AIs) in early breast cancer is associated with an increased risk of cardiovascular events and bone fractures, according to results from a study published in the Journal of the National Cancer Institute.

A higher percentage of body fat – specifically fat in the abdominal area – was associated with an increased risk of certain cancers for postmenopausal women, according to a recent study presented at the 2017 European Society of Medical Oncology (ESMO) Congress in Madrid, Spain.

Ovarian cancer is a hard taskmaster, but cancer teaches us important life, faith and family lessons

Sharing our cancer stories allowed us to share much more.

One cancer patient’s story of being impacted by both hurricanes Harvey and Irma.

Patients, survivors and their families joined medical staff in a day of fun and entertainment sponsored by the John Theurer Cancer Center.

Can a class of drugs commonly prescribed to help lower cholesterol levels protect against breast cancer?

Keytruda (pembrolizumab) produced better overall survival (OS) rates than chemotherapy for patients with recurrent, advanced urothelial carcinoma.

After losing someone to cancer, people may need continued support.

Emotional care - just like life-saving treatment - is critical to survival.

Every six months, I get an MRI to check for recurrence or growth of my brain tumor. This is one of those times. To prepare for tomorrow, I try to remember not to forgo today.

Women with breast cancer who are positive for the BRCA gene mutation may be more likely to encounter difficulty with fertility preservation compared to women with breast cancer who have tested negative for the BRCA mutation.

Patients with advanced gastric cancer tend to use their health care resources more often and have a worse quality of life than those without the disease

While many people associate the strategy with the end of life, studies have shown that employing palliative care earlier in the course of treatment can benefit patients’ outcomes and quality of life.

Side effects that arise months or years after adolescents and young adults (AYAs) have completed cancer treatment — known as late effects — can significantly affect both careers and quality of life in this population.

Nausea and vomiting are no longer top concerns for patients undergoing chemotherapy. Socio-psychological concerns, instead, have jumped to the forefront.

A phase 2 trial – which is still enrolling patients – is investigating multiple targeted agents for the treatment of patients with glioblastoma (GBM).

According to the results of a recent study conducted in China, patients with stage 3B/4 non-small cell lung cancer (NSCLC) saw a 3.3-month increase in median progression-free survival (PFS) when taking Conmana (icotinib) compared to those who were taking chemotherapy.

Women want bilateral mastectomy more often, and many are getting it.

It is normal to feel guilt when you survived cancer and friends and family members do not. Here is one writer's way of coping.

Be prepared. After cancer, other medical issues can trigger outsized emotional responses.

The Food and Drug Administration (FDA) recently released a statement providing data from the two phase 3 trials testing Keytruda (pembrolizumab) in patients with multiple myeloma. The trials were placed on clinical holds by the FDA in July, after concerns arose regarding the drug’s safety in this group of patients.

It's been said that reaching the ten-year mark means you are home free. But are you?